Excelsior, MN – UltiMed, Inc. is proud to celebrate the 20th
anniversary of the De Smet, South Dakota manufacturing site.
Over the last twenty years, the UltiMed, Inc. plant in De Smet has grown from a small team to a fully staffed facility including Quality Assurance, Maintenance, Production, Receiving, and Engineering departments.
In 2001, UltiMed, Inc. started manufacturing syringes in the De Smet facility. With one machine for gaskets, a second machine for barrels, and a third machine for printing. As business expanded, the facility was able to add additional machines for syringe manufacturing, as well as pen needle assembly with the most recent pen needle line being installed in 2019. Each UltiMed, Inc employee goes through a rigorous training process to ensure they are fully equipped to operate the machinery and ensure product meets quality standards of the FDA. Today the UltiMed De Smet facility has almost 70,000 square feet of manufacturing space and maintains ISO, BPI, OSHA and Canadian MDSAP certifications.
UltiMed’s De Smet facility services customers across the country (and Canada), and ships product directly from the De Smet facility to help consumers and animals impacted by diabetes. UltiMed is also proud to service patients needing immunizations or other treatments that are administered via injection and is the only pen needle manufacturing facility in the United States.
In addition to the wide distribution capabilities at the facility, UltiMed is also the creator of the only all-in-one pen needle and syringe product that combines needles with a sharps container. The product adheres to safe disposal guidelines in all 50 states and provides a safe and compliant solution to protect families, homes, communities and the environment.
With the growth of UltiMed, multiple roles have been added to the company and helped provide additional jobs and opportunities in the De Smet community. UltiMed also participates in programs that give back to the community. Additionally, UltiMed honors and continues to align with South Dakota’s efforts to grow the bioscience industry in the state. De Smet has been a tremendous fit for both the objectives of the state and the company.
“We are proud to have developed our business in De Smet over the last two decades, and look forward to continued growth, success and support of biotech industries in South Dakota for years to come,” says Jim Erickson, President of UltiMed, Inc.